Pharmacology Potpourri: Topicals to Orals in Ocular Disease Management

Course overview

Any use of a drug not listed on the label is considered off-label. Off-label uses include giving an approved drug for a disease or indication other than the disease for which it is approved; at a different dose, frequency or route of administration than specified in the label; or to treat a child when the product is approved to treat adults. Although the Food and Drug Administration (FDA) label has important marketing implications, the use of an approved product by providers is not restricted by the FDA to the limitations of the label. Providers are allowed to use FDA-approved drugs in the treatment of a specific patient as medical practice. The FDA recognizes that off-label use of drugs by providers is often appropriate and may represent the standard of care. This presentation will discuss investigational use, informed consent and insurance carrier criteria considerations when prescribing an off-label medication